Drug Shortage Report for AURO-PERINDOPRIL

Last updated on 2024-12-03 History
Report ID 199682
Drug Identification Number 02459833
Brand name AURO-PERINDOPRIL
Common or Proper name PERINDOPRIL
Company Name AURO PHARMA INC
Market Status MARKETED
Active Ingredient(s) PERINDOPRIL ERBUMINE
Strength(s) 8MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 3x10 Blst
ATC code C09AA
ATC description ACE INHIBITORS, PLAIN
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2023-07-21
Estimated end date 2024-11-30
Actual end date 2024-12-02
Shortage status Resolved
Updated date 2024-12-03
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3700 STEELES AVENUE WEST, SUITE 402
WOODBRIDGE, ONTARIO
CANADA L4L 8K8
Company contact information Anahita Rostami

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v45 2024-12-03 English Compare
v44 2024-12-02 French Compare
v43 2024-12-02 English Compare
v42 2024-10-28 French Compare
v41 2024-10-28 English Compare
v40 2024-09-27 French Compare
v39 2024-09-27 English Compare
v38 2024-08-27 French Compare
v37 2024-08-27 English Compare
v36 2024-07-29 French Compare
v35 2024-07-29 English Compare
v34 2024-07-15 French Compare
v33 2024-07-15 English Compare
v32 2024-07-02 French Compare
v31 2024-07-02 English Compare
v30 2024-04-18 French Compare
v29 2024-04-18 English Compare
v28 2024-03-27 French Compare
v27 2024-03-27 English Compare
v26 2024-02-12 French Compare

Showing 1 to 20 of 45